Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT

We have analyzed the incidence and risk factors for the occurrence of invasive aspergillosis (IA) among 219 consecutive recipients of an allogeneic hematopoietic SCT after a reduced-intensity conditioning regimen (Allo-RIC). Twenty-seven patients developed an IA at a median of 218 days (range 24-205...

Full description

Bibliographic Details
Authors: Martino, R, Pinana, JL, Parody, R, Valcarcel, D, Sureda, A, Brunet, S, Briones, J, Delgado, J, Sanchez, F, Rabella, N, Sierra, J
Format: article
Status:Published version
Publication Date:2009
Country:España
Institution:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repository:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p12934
Online Access:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12934
Access Level:Open access
Keyword:aspergillosis
allogeneic hematopoietic SCT
reduced-intensity conditioning
respiratory virus infections
Description
Summary:We have analyzed the incidence and risk factors for the occurrence of invasive aspergillosis (IA) among 219 consecutive recipients of an allogeneic hematopoietic SCT after a reduced-intensity conditioning regimen (Allo-RIC). Twenty-seven patients developed an IA at a median of 218 days (range 24-2051) post-Allo-RIC, for a 4-year incidence of 13% (95% confidence interval 4-24%). In multivariate analysis, risk factors for developing IA were steroid therapy for moderate-to-severe graft vs host disease (GVHD) (Hazard Ratio (HR) 2.9, P = 0.03), occurrence of a lower respiratory tract infection (LRTI) by a respiratory virus (RV) (HR 4.3, P < 0.01) and CMV disease (HR 2.8, P = 0.03). Variables that decreased survival after Allo-RIC were advanced disease phase (HR 1.9, P = 0.02), steroid therapy for moderate-to-severe GVHD (HR 2.2, P < 0.01), not developing chronic GVHD (HR 4.3, P < 0.01), occurrence of LRTI by an RV (HR 3.4, P < 0.01 ) and CMV disease (HR 2, P 0.01), whereas occurrence of IA had no effect on survival (P = 0.5). Our results show that IA is a common infectious complication after an Allo-RIC, which occurs late post-transplant and may not have a strong effect on survival. An important observation is the possible role of LRTI by conventional RVs as risk factors for IA. Bone Marrow Transplantation (2009) 44, 749-756; doi:10.1038/bmt.2009.78; published online 27 April 2009